The mission of the Clinical Trials Network (CTN) is to improve the quality of drug abuse treatment throughout the country using science as the vehicle.
Overview
The CTN provides an enterprise in which the National Institute on Drug Abuse, treatment researchers, and community-based service providers cooperatively develop, validate, refine, and deliver new treatment options to patients in community-level clinical practice.
Objectives
The unique partnership between community treatment providers and academic research leaders aims to achieve the following objectives:
Conducting studies of behavioral, pharmacological, and integrated behavioral and pharmacological treatment interventions of therapeutic effect in rigorous, multi-site clinical trials to determine effectiveness across a broad range of community-based treatment settings and diversified patient populations
Ensuring the transfer of research results to physicians, clinicians, providers, and patients.
Network Organization
The CTN framework consists of sixteen Nodes (Regional Research and Training Centers - RRTCs linked with five to ten or more Community-based Treatment programs - CTPs), a Clinical Coordinating Center, and a Data and Statistical Center.
Southern Consortium Node
10 research CTPs in North Carolina, South Carolina and Georgia
25 treatment centers in South Carolina, Georgia and Mississippi
The consortium was formed to help facilitate promulgation of CTN findings and provide a larger pool of potential CTN research sites. The CTPs of the Southern Consortium provide services to adults and adolescents in both rural and urban areas and represent a wide range of treatment settings and modalities including 12-step, family therapy, medication management, inpatient detoxification, drug court, narcotic replacement therapy, and cognitive behavioral therapy.